12-79689982-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002583.4(PAWR):c.263G>A(p.Gly88Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000129 in 1,321,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002583.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAWR | NM_002583.4 | c.263G>A | p.Gly88Asp | missense_variant | 2/7 | ENST00000328827.9 | NP_002574.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAWR | ENST00000328827.9 | c.263G>A | p.Gly88Asp | missense_variant | 2/7 | 1 | NM_002583.4 | ENSP00000328088 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151654Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000241 AC: 1AN: 4154Hom.: 0 AF XY: 0.000410 AC XY: 1AN XY: 2438
GnomAD4 exome AF: 0.0000103 AC: 12AN: 1170142Hom.: 0 Cov.: 32 AF XY: 0.0000177 AC XY: 10AN XY: 563682
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151654Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74066
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.263G>A (p.G88D) alteration is located in exon 2 (coding exon 1) of the PAWR gene. This alteration results from a G to A substitution at nucleotide position 263, causing the glycine (G) at amino acid position 88 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at